Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide is an experimental small molecule compound belonging to the class of aromatic anilides and indazoles. It acts as a selective inhibitor of cyclin-dependent kinase 2 (CDK2), a serine/threonine protein kinase involved in cell cycle regulation. By inhibiting CDK2, this compound may interfere with cell proliferation and has been investigated for potential anticancer activity. There are no approved indications or clinical trials reported for this molecule; it remains at the preclinical/experimental stage[1][6][3].
- Other names
- N-(4-Sulfamoylphényl)-1H-indazole-3-carboxamide1H-Indazole-3-carboxamide, N-[4-(aminosulfonyl)phenyl]-N-(4-sulphamoylphenyl)-1H-indazole-3-carboxamide
02
Targets
CDK2 (Cyclin-dependent kinase 2)
Beyond the preview
Go deeper on N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide.